Use of Recombinant Activated Factor VII for Controlling Refractory Postoperative Bleeding in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass
- 31 December 2011
- journal article
- Published by Elsevier BV in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 25 (6), 987-994
- https://doi.org/10.1053/j.jvca.2011.05.012
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Safety of Recombinant Activated Factor VII in Randomized Clinical TrialsNew England Journal of Medicine, 2010
- Thrombotic Risk of Recombinant Factor Seven in Pediatric Cardiac Surgery: A Single Institution ExperienceThe Annals of Thoracic Surgery, 2010
- Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypassPediatric Anesthesia, 2009
- Thrombosis in children with cardiac pathology: analysis of acquired and inherited risk factorsBlood Coagulation & Fibrinolysis, 2008
- Coagulopathy and Inflammation in Neonatal Heart Surgery: Mechanisms and StrategiesThe Annals of Thoracic Surgery, 2006
- Fibrinogen in Children Undergoing Cardiac Surgery: Is It Effective?Anesthesia & Analgesia, 2004
- Recombinant Factor VIIa to Control Excessive Bleeding Following Surgery for Congenital Heart Disease in Pediatric PatientsJournal of Intensive Care Medicine, 2004
- Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgeryPediatric Critical Care Medicine, 2003
- Recombinant factor VIIa to treat bleeding after cardiac surgery in an infantPediatric Critical Care Medicine, 2003
- Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgeryBlood Coagulation & Fibrinolysis, 2000